BioStock: Positive results for Neola presented at prominent conference

At the recent annual jENS conference prominent neonatologists from all over Europe gathered to learn about the latest developments in the field. One of the presenters was Jurate Panaviene, who announced the results of the NIOMI study, in which Neola Medical’s medical device Neola was evaluated on 100 newborn babies. BioStock reached out to the company’s CEO Hanna Sjöström to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/10/positive-results-for-neola-presented-at-prominent-conference/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se